Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression

Buprenorphine is currently being studied for treatment-resistant depression because of its rapid effect, relative safety, and unique pharmacodynamics. To understand the neural impact of buprenorphine in depression, we examined acute limbic and reward circuit changes during an intervention with low-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chemin, Karim, Helmet T., Pecina, Marta, Aizenstein, Howard J., Lenze, Eric J., Blumberger, Daniel M., Mulsant, Benoit H., Kharasch, Evan D., Reynolds III, Charles F., Karp, Jordan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356006/
https://www.ncbi.nlm.nih.gov/pubmed/30685701
http://dx.doi.org/10.1016/j.nicl.2019.101679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356006/
https://www.ncbi.nlm.nih.gov/pubmed/30685701
http://dx.doi.org/10.1016/j.nicl.2019.101679

Ejemplares similares